Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients

Background: It is documented that COVID-19 survivors have prolonged morbidity and functional impairment for many years. Data regarding post-COVID-19 lung functions is lacking from the Indian population. We aim to evaluate the lung functions in such patients after 3–6 months of hospital discharge. Me...

Full description

Saved in:
Bibliographic Details
Main Authors: K Naja, Durga Shankar Meena, Deepak Kumar, Naveen Dutt, Gopal K. Bohra, Ravisekhar Gadepalli, Mithu Banerjee, Mahendra K. Garg, Sanjeev Misra
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-12-01
Series:Journal of Family Medicine and Primary Care
Subjects:
Online Access:https://journals.lww.com/10.4103/jfmpc.jfmpc_2034_23
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1841545842647891968
author K Naja
Durga Shankar Meena
Deepak Kumar
Naveen Dutt
Gopal K. Bohra
Ravisekhar Gadepalli
Mithu Banerjee
Mahendra K. Garg
Sanjeev Misra
author_facet K Naja
Durga Shankar Meena
Deepak Kumar
Naveen Dutt
Gopal K. Bohra
Ravisekhar Gadepalli
Mithu Banerjee
Mahendra K. Garg
Sanjeev Misra
author_sort K Naja
collection DOAJ
description Background: It is documented that COVID-19 survivors have prolonged morbidity and functional impairment for many years. Data regarding post-COVID-19 lung functions is lacking from the Indian population. We aim to evaluate the lung functions in such patients after 3–6 months of hospital discharge. Methods: In this prospective observational study, patients were assessed 3 to 6 months post-discharge and underwent standardized pulmonary function tests (PFTs) and CT Thorax if required. The following parameters were measured and correlated with the disease severity: Forced Vital Capacity (FVC), Forced Expiratory Volume in the First Second (FEV1), Forced Expiratory Flows at 25 and 75% of FVC (FEF25%-75%), Peak Expiratory Flow (PEF) and FEV1/FVC. Results: A total of 52 post-COVID-19 patients were enrolled in the study, with a median age of 43 years (78.8% males). 44.2% of patients had mild disease, 26.9% had moderate disease and 23.1% had severe disease at hospital admission. A restrictive pattern was seen in 20.8% of patients. The mean value of FEV1 and FVC decreased as the disease severity increased. FEV1: mild-3.21 ± 0.71, moderate-2.62 ± 0.61 and severe- 2.51 ± 0.72, P = 0.02; FVC: mild-3.69 ± 0.81, moderate-3.04 ± 0.71 and severe- 2.93 ± 0.87, P = 0.02. After adjusting the confounding factors, the mean pulmonary function values were lower in the patients who required oxygen support, with a significant difference in FEV1, FVC, PEF and FEF 25–75% with P values of 0.025, 0.046, 0.028 and 0.007, respectively. 66.67% had abnormal HRCT findings. Age and high LDH were correlated with HRCT abnormality with P values of 0.015 and 0.024. Age >50 years was found to be an independent predictor of the subsequent development of abnormality on the HRCT thorax. Conclusions: Patients with COVID-19 pneumonia, which required oxygen, especially severe disease at the time of hospitalization, had a higher rate of abnormal spirometry than patients with mild symptoms. Follow-up CT scans obtained within six months of disease onset showed abnormalities in more than half of patients, particularly elderly patients.
format Article
id doaj-art-8b9d42f9574a4a29bb643ead3c338260
institution Kabale University
issn 2249-4863
2278-7135
language English
publishDate 2024-12-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Family Medicine and Primary Care
spelling doaj-art-8b9d42f9574a4a29bb643ead3c3382602025-01-11T09:53:08ZengWolters Kluwer Medknow PublicationsJournal of Family Medicine and Primary Care2249-48632278-71352024-12-0113125544554910.4103/jfmpc.jfmpc_2034_23Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patientsK NajaDurga Shankar MeenaDeepak KumarNaveen DuttGopal K. BohraRavisekhar GadepalliMithu BanerjeeMahendra K. GargSanjeev MisraBackground: It is documented that COVID-19 survivors have prolonged morbidity and functional impairment for many years. Data regarding post-COVID-19 lung functions is lacking from the Indian population. We aim to evaluate the lung functions in such patients after 3–6 months of hospital discharge. Methods: In this prospective observational study, patients were assessed 3 to 6 months post-discharge and underwent standardized pulmonary function tests (PFTs) and CT Thorax if required. The following parameters were measured and correlated with the disease severity: Forced Vital Capacity (FVC), Forced Expiratory Volume in the First Second (FEV1), Forced Expiratory Flows at 25 and 75% of FVC (FEF25%-75%), Peak Expiratory Flow (PEF) and FEV1/FVC. Results: A total of 52 post-COVID-19 patients were enrolled in the study, with a median age of 43 years (78.8% males). 44.2% of patients had mild disease, 26.9% had moderate disease and 23.1% had severe disease at hospital admission. A restrictive pattern was seen in 20.8% of patients. The mean value of FEV1 and FVC decreased as the disease severity increased. FEV1: mild-3.21 ± 0.71, moderate-2.62 ± 0.61 and severe- 2.51 ± 0.72, P = 0.02; FVC: mild-3.69 ± 0.81, moderate-3.04 ± 0.71 and severe- 2.93 ± 0.87, P = 0.02. After adjusting the confounding factors, the mean pulmonary function values were lower in the patients who required oxygen support, with a significant difference in FEV1, FVC, PEF and FEF 25–75% with P values of 0.025, 0.046, 0.028 and 0.007, respectively. 66.67% had abnormal HRCT findings. Age and high LDH were correlated with HRCT abnormality with P values of 0.015 and 0.024. Age >50 years was found to be an independent predictor of the subsequent development of abnormality on the HRCT thorax. Conclusions: Patients with COVID-19 pneumonia, which required oxygen, especially severe disease at the time of hospitalization, had a higher rate of abnormal spirometry than patients with mild symptoms. Follow-up CT scans obtained within six months of disease onset showed abnormalities in more than half of patients, particularly elderly patients.https://journals.lww.com/10.4103/jfmpc.jfmpc_2034_23covid-19lung function testpftpneumoniaspirometry
spellingShingle K Naja
Durga Shankar Meena
Deepak Kumar
Naveen Dutt
Gopal K. Bohra
Ravisekhar Gadepalli
Mithu Banerjee
Mahendra K. Garg
Sanjeev Misra
Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients
Journal of Family Medicine and Primary Care
covid-19
lung function test
pft
pneumonia
spirometry
title Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients
title_full Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients
title_fullStr Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients
title_full_unstemmed Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients
title_short Evaluation of the long-term effects of COVID-19 on pulmonary functions in recovered patients
title_sort evaluation of the long term effects of covid 19 on pulmonary functions in recovered patients
topic covid-19
lung function test
pft
pneumonia
spirometry
url https://journals.lww.com/10.4103/jfmpc.jfmpc_2034_23
work_keys_str_mv AT knaja evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT durgashankarmeena evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT deepakkumar evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT naveendutt evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT gopalkbohra evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT ravisekhargadepalli evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT mithubanerjee evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT mahendrakgarg evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients
AT sanjeevmisra evaluationofthelongtermeffectsofcovid19onpulmonaryfunctionsinrecoveredpatients